Endometrics develops a novel easy-to-use solution for early diagnosis of endometriosis using a non-invasive test that analyzes menstrual blood samples and proprietary genomic biomarkers
Endometrics develops a novel easy-to-use solution for early diagnosis of endometriosis using a non-invasive test that analyzes menstrual blood samples and proprietary genomic biomarkers.
The top three firms on F4's Biotech & Life Sciences investor list.